InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Discover the complete record of transactions filed by Koconis John, 董事长兼首席执行官. Insider active across 1 company, notably Timber Pharmaceuticals, Inc.. Cumulatively, 2 filings have been logged. Breakdown: 1 buy · 0 sell. Total volume traded: €7k. History available since 15 December 2021. The latest transaction was disclosed on 20 August 2023 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 条申报中的 2 条
John Koconis is the CEO & President of Timber Pharmaceuticals, Inc. In this role, he is responsible for the strategic direction and management of the company's operations. John is committed to promoting innovation and efficiency, ensuring that Timber Pharmaceuticals meets its financial objectives. His experience in the pharmaceutical sector is a major asset for the company.